Market Snapshot
S&P Futures
Dow Futures
NASDAQ Futures
Illumina, Inc.NASDAQ( ILMN )
433.20$-1.39 -0.32 %
At close
04:00 PM
Stock Snapshot
434.59
Prev. Close
436.06
Open
63.97B
Market Cap
Number of Shares
431.28
Day Low
436.67
Day High
433.20
82.96
P/E Ratio
146.22M
Free Float in %
5.22
EPS 2021
35.48
Book Value per Share
29.03
Cash Flow per Share
Illumina, Inc. (ILMN)
Illumina, Inc. (ILMN) stock rallied over -0.32% intraday to trade at $433.20 share on NASDAQ. The stock opened with a gain of % at $436.06 and touched an intraday high of $436.67, rising 0.48% against the last close of $434.59. The stock went to a low of $431.28 during the session.
Historical Data
| Date | Open | Close | Daily High | Daily Low | Volume |
|---|---|---|---|---|---|
| 2021-09-10 | $461.54 | $458.21 | $465.59 | $457.78 | 444,236 |
| 2021-09-03 | $466.03 | $466.98 | $471.10 | $465.00 | 51,790,000 |
| 2021-09-02 | $465.15 | $469.54 | $470.83 | $464.75 | 52,730,000 |
| 2021-09-01 | $456.55 | $463.02 | $470.34 | $455.07 | 62,080,000 |
| 2021-08-31 | $459.35 | $457.16 | $459.35 | $448.68 | 118,990,000 |
| 2021-08-30 | $463.50 | $457.00 | $464.00 | $454.05 | 122,840,000 |
| 2021-08-27 | $471.71 | $464.58 | $477.16 | $463.90 | 83,970,000 |
| 2021-08-26 | $484.38 | $470.86 | $486.10 | $465.54 | 72,980,000 |
| 2021-08-25 | $479.67 | $487.47 | $488.57 | $476.35 | 48,090,000 |
| 2021-08-24 | $473.70 | $479.67 | $481.30 | $471.00 | 140,970,000 |
| 2021-08-23 | $489.10 | $478.33 | $492.29 | $476.67 | 111,290,000 |
Illumina, Inc.
Employees
7800
7800
Sector
Healthcare
Healthcare
Sales or Revenue
3.97B
3.97B
Industry
Diagnostics & Research
Diagnostics & Research
5Y Sales Change
7.90
7.90
Fiscal Year Ends
2021-01-02
2021-01-02
Illumina, Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is headquartered in San Diego, California.